HUMAN BODY-DERIVED LACTOBACILLUS FERMENTUM MG4231 OR LACTOBACILLUS FERMENTUM MG4244 STRAIN HAVING ANTI-OBESITY ACTIVITY AND COMPOSITION COMPRISING SAME

摘要

The present invention relates to a human body-derived Lactobacillus fermentum MG4231 or Lactobacillus fermentum MG4244 and a pharmaceutical composition, food composition, a quasi-drug composition, and a health functional food, each of which comprises the same as an effective ingredient for preventing or treating obesity-related diseases. The Lactobacillus fermentum MG4231 or Lactobacillus fermentum MG4244 strain of the present invention exhibits the anti-obesity activity of inhibiting the activity of lipase enzymes, the differentiation of preadipocytes, and the accumulation of triglyceride, has an excellent ability to form colonies on epithelial cells of the digestive duct through excellent self-aggregation ability, and is resistant to acid and bile salts, thereby finding various applications in pharmaceutical compositions, food compositions or quasi-drug compositions, and health functional foods for treating and preventing obesity-related diseases.